FightSMA Announces Introduction in the House of Representatives of the National Pediatric Research Network Act (NPRNA)
A bill to authorize the NIH to support the creation of up to 20 pediatric research consortia focused on diseases such as spinal muscular atrophy (SMA) was introduced in the U.S. House of Representatives.
Alexandria, VA (PRWEB) July 20, 2012
A bill to authorize the National Institutes of Health (NIH) to support the creation of up to 20 pediatric research consortia focused on diseases such as spinal muscular atrophy (SMA) was introduced yesterday in the U.S. House of Representatives.
The bipartisan bill, called the National Pediatric Research Network Act (NPRNA) is being introduced by Representatives Cathy McMorris Rodgers (R-WA) and Lois Capps (D-CA). It is designed in part to help achieve the goal of securing additional federal resources to accelerate clinical trials for spinal muscular atrophy (SMA).
“We are thrilled about this bill which is the result of the dedication of so many in the SMA community,” said Martha Slay, founder and immediate past president of FightSMA. “Legislation to benefit SMA is at the heart of the FightSMA mission.”
“Over the past year, FightSMA has worked with our champions in the Congress, Representatives McMorris Rodgers and Lois Capps, on this important legislation. With the support of longtime FightSMA ally House Majority Leader Eric Cantor (R-VA), these two key members of the House Energy and Commerce Committee´s Subcommittee on Health have collaborated to craft bipartisan legislation that will advance translational research and clinical trials for a variety of rare pediatric disorders, with SMA serving as a model disease,” said Ms. Slay.
“I am proud to join Rep. Capps in introducing the very important National Pediatric Research Network Act. She has been an instrumental leader in the fight to promote pediatric research for genetic disorders, especially spinal muscular atrophy and Down syndrome,” said Rep. McMorris Rodgers. “As the mother of a son with Down syndrome, I am confident this legislation will go a long way to improving the lives of those with genetic disorders. I look forward to working in a bipartisan way to make sure this bill is signed into law.”
“I am proud to co-author this legislation with my friend (Rep.) Cathy McMorris Rodgers, which would go a long way to increasing and improving research on children´s illnesses—especially rare and complex diseases—and developing new treatments to fight them,” said Congresswoman Capps. “Every parent´s worst fear is that their child becomes sick, and we owe it to all parents to do what we can to fight childhood illnesses. I would also like to thank my constituents, Bill and Victoria Strong, for their tireless work on behalf of their daughter, Gwendolyn, and all children with Spinal Muscular Atrophy and other rare diseases. Their dedication to fighting this terrible disease has been an inspiration for me and a driving force behind this bill,” said Congresswoman Capps.
Expanding on a previous pediatric research measure by Congresswoman Diana DeGette (D-CO), the bill calls for an appropriate number of new consortia to focus primarily on rare diseases, and specifically mentions SMA among the diseases that should be included. The bill directs NIH to support consortia that conduct multisite clinical trials of therapies for pediatric rare diseases.
“FightSMA and our congressional sponsors have collaborated directly with senior health staff on the House Energy and Commerce Committee in drafting this legislation,” said Mike Calise, Chair of the FightSMA Board of Directors, “and we will continue to work with them to ensure that the committee considers the bill in a timely manner.”
The process of building bipartisan support for a companion bill in the Senate has begun, working with the Senate Committee on Health, Education, Labor and Pensions (HELP). FightSMA´s objective is to have a bill introduced in the Senate as early as possible. “We will continue to push aggressively for enactment of this important legislation in 2012,” said Calise.
FightSMA, an international nonprofit group, was founded in 1991 to accelerate a treatment or cure for spinal muscular atrophy (SMA), the leading genetic cause of infant death. Since its formation, FightSMA has awarded research grants at more than 40 universities and research institutions in the United States, Canada, France, the United Kingdom, and Italy.
For more information, visit: http://www.fightsma.org or contact Danielle Chan at 703.647.5032
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebfightsma/nprna/prweb9721737.htm